<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fu J</submitter><funding>BLRD VA</funding><funding>NHLBI NIH HHS</funding><pagination>1539-47</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4180715</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(7)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Interleukin-8 (IL-8) receptors IL8RA and IL8RB (IL8RA/B) on neutrophil membranes bind to IL-8 with high affinity and play a critical role in neutrophil recruitment to sites of injury and inflammation. This study tested the hypothesis that administration of rat pulmonary arterial endothelial cells (ECs) overexpressing IL8RA/B can accelerate the adhesion of ECs to the injured lung and inhibit monocrotaline-induced pulmonary inflammation, arterial thickening and hypertension, and right ventricular hypertrophy.&lt;h4>Approach and results&lt;/h4>The treatment groups included 10-week-old ovariectomized Sprague-Dawley rats that received subcutaneous injection of PBS (vehicle), a single injection of monocrotaline (monocrotaline alone, 60 mg/kg, SC), monocrotaline followed by intravenous transfusion of ECs transduced with the empty adenoviral vector (null-EC), and monocrotaline followed by intravenous transfusion of ECs overexpressing IL8RA/B (1.5 × 10(6) cells/rat). Two days or 4 weeks after monocrotaline treatment, endothelial nitric oxide synthase, inducible nitric oxide synthase, cytokine-induced neutrophil chemoattractant-2β (IL-8 equivalent in rat), and monocyte chemoattractant protein-1 expression, neutrophil and macrophage infiltration into pulmonary arterioles, and arteriolar and alveolar morphology were measured by histological and immunohistochemical techniques. Proinflammatory cytokine/chemokine protein levels were measured by Multiplex rat-specific magnetic bead-based sandwich immunoassay in total lung homogenates. Transfusion of ECs overexpressing IL8RA/B significantly reduced monocrotaline-induced neutrophil infiltration and proinflammatory mediator (IL-8, monocyte chemoattractant protein-1, inducible nitric oxide synthase, cytokine-induced neutrophil chemoattractant, and macrophage inflammatory protein-2) expression in lungs and pulmonary arterioles and alveoli, pulmonary arterial pressure, and pulmonary arterial and right ventricular hypertrophy and remodeling.&lt;h4>Conclusions&lt;/h4>These provocative findings suggest that targeted delivery of ECs overexpressing IL8RA/B is effective in repairing the injured pulmonary vasculature.</pubmed_abstract><journal>Arteriosclerosis, thrombosis, and vascular biology</journal><pubmed_title>Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.</pubmed_title><pmcid>PMC4180715</pmcid><funding_grant_id>I01 BX001431</funding_grant_id><funding_grant_id>R01 HL080017</funding_grant_id><funding_grant_id>R01 HL087980</funding_grant_id><funding_grant_id>R01HL116727</funding_grant_id><funding_grant_id>R01 HL116727</funding_grant_id><funding_grant_id>R01HL087980</funding_grant_id><funding_grant_id>R01 HL044195</funding_grant_id><pubmed_authors>Chen YF</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Fu J</pubmed_authors><pubmed_authors>Xing DD</pubmed_authors><pubmed_authors>Creighton JR</pubmed_authors><pubmed_authors>Hage FG</pubmed_authors><pubmed_authors>Oparil S</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.</name><description>&lt;h4>Objective&lt;/h4>Interleukin-8 (IL-8) receptors IL8RA and IL8RB (IL8RA/B) on neutrophil membranes bind to IL-8 with high affinity and play a critical role in neutrophil recruitment to sites of injury and inflammation. This study tested the hypothesis that administration of rat pulmonary arterial endothelial cells (ECs) overexpressing IL8RA/B can accelerate the adhesion of ECs to the injured lung and inhibit monocrotaline-induced pulmonary inflammation, arterial thickening and hypertension, and right ventricular hypertrophy.&lt;h4>Approach and results&lt;/h4>The treatment groups included 10-week-old ovariectomized Sprague-Dawley rats that received subcutaneous injection of PBS (vehicle), a single injection of monocrotaline (monocrotaline alone, 60 mg/kg, SC), monocrotaline followed by intravenous transfusion of ECs transduced with the empty adenoviral vector (null-EC), and monocrotaline followed by intravenous transfusion of ECs overexpressing IL8RA/B (1.5 × 10(6) cells/rat). Two days or 4 weeks after monocrotaline treatment, endothelial nitric oxide synthase, inducible nitric oxide synthase, cytokine-induced neutrophil chemoattractant-2β (IL-8 equivalent in rat), and monocyte chemoattractant protein-1 expression, neutrophil and macrophage infiltration into pulmonary arterioles, and arteriolar and alveolar morphology were measured by histological and immunohistochemical techniques. Proinflammatory cytokine/chemokine protein levels were measured by Multiplex rat-specific magnetic bead-based sandwich immunoassay in total lung homogenates. Transfusion of ECs overexpressing IL8RA/B significantly reduced monocrotaline-induced neutrophil infiltration and proinflammatory mediator (IL-8, monocyte chemoattractant protein-1, inducible nitric oxide synthase, cytokine-induced neutrophil chemoattractant, and macrophage inflammatory protein-2) expression in lungs and pulmonary arterioles and alveoli, pulmonary arterial pressure, and pulmonary arterial and right ventricular hypertrophy and remodeling.&lt;h4>Conclusions&lt;/h4>These provocative findings suggest that targeted delivery of ECs overexpressing IL8RA/B is effective in repairing the injured pulmonary vasculature.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jul</publication><modification>2025-04-07T03:23:45.414Z</modification><creation>2019-03-27T01:36:46Z</creation></dates><accession>S-EPMC4180715</accession><cross_references><pubmed>24790141</pubmed><doi>10.1161/ATVBAHA.114.303821</doi><doi>10.1161/atvbaha.114.303821</doi></cross_references></HashMap>